The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete. |
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
| | OMB APPROVAL | | OMB Number: | 3235-0006 | | Expires: | Oct 31, 2018 | | Estimated average burden | | hours per response: | 23.8 | | |
| Report for the Calendar Year or Quarter Ended: | 03-31-2021 |
| Check here if Amendment | | Amendment Number: |
| This Amendment (Check only one.): | | is a restatement. |
| | adds new holdings entries. |
| Institutional Investment Manager Filing this Report: |
| Name: | SV Health Investors, LLC |
| Address: | ONE BOSTON PLACE |
| 201 WASHINGTON STREET, SUITE 3900 |
| BOSTON, MA 02108 |
| Form 13F File Number: | 028-16271 |
The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.
| Person Signing this Report on Behalf of Reporting Manager: |
| Name: | Brent M. Faduski |
| Title: | Officer |
| Phone: | (617) 367-8100 |
| Signature, Place, and Date of Signing: |
| /s/ Brent M. Faduski | Boston, MA | 05-17-2021 |
| [Signature] | [City, State] | [Date] |
| The filing of this report shall not be deemed an admission, for purposes of Section 13(t), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended, and the rules thereunder, or for any other pmpose, that the Rep011ing Manager or any other person (including Other Managers or Other Included Managers named herein) is the beneficial owner of any securities. SV Health Investors, LLC, a Delaware limited liability company ("Investors"), is an institutional investment manager subject to Section 13(t) of the Securities Exchange Act of 1934 and the rules promulgated thereunder. SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners IV" and together with SVLS IV LP, the "Fund IV Entities"), and SV Life Sciences Fund V, L.P. ("SVLS V LP") and SV Life Sciences Fund V Strategic Piuincrs, L.P. ("Strategic Partners V" and together with SVLS V LP, the "Fund V Entities"), and SV Life Sciences Fund VJ, L.P. ("SVLS VJ LP") and SV Life Sciences Fund VJ Strategic Partners, L.P. ("Strategic Partners VI" and together with SVLS VJ LP, the "Fund VI Entities"), which are each Delaware limited partnerships (the Fund IV Entities, the Fund V Entities and the Fund VI Entities together, the "Funds"), directly own certain security positions rep01ied by Investors, which is the investment adviser of the Funds. SV Life Sciences Fund VI (GP), L.P., a Delaware limited pa1inership ("SVLS VI GP") is the general partner of the Fund VJ Entities, and SVLSF VI, LLC, a Delaware limited liability company is the general pat1ner of SVLS VI GP. Certain of the security positions reported by Investors are also being reported by SVLS Vl GP and SVLSF VI, LLC (together, the "GPs"). Each of SVLS VJ GP, SVLSF VI, LLC and Investors may be deemed to share voting power and control over the shares held by the Fund VI Entities. Investors may also be deemed to share voting power and control over the shares held by the Fund IV and Fund V Entities. Each of the GPs and Investors disclaim beneficial ownership of the shares held by the Funds except to the extent of any pecuniary interest therein. |
| Report Type (Check only one.): |
| X | 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) |
| | 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) |
| | 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) |
| Form 13F Summary Page |
| Report Summary: |
| Number of Other Included Managers: | 2 | | |
| Form 13F Information Table Entry Total: | 8 |
| Form 13F Information Table Value Total: | 266,962 |
| (thousands) |
|
| List of Other Included Managers: |
| Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. |
| [If there are no entries in this list, state “NONE” and omit the column headings and list entries.] |
| No. | Form 13F File Number | Name |
| 1 | 028-19256 | SVLSF VI, LLC |
| 2 | 028-19255 | SV Life Sciences Fund VI (GP), L.P. |
